Successful treatment of COVID-19-associated collapsing glomerulopathy: 22 months of follow-up
Description
The term COVAN (COVID-19-associated nephropathy) has been used to describe collapsing focal segmental glomerulosclerosis (FSGS) in individuals who have been infected with the SARS-CoV-2. This helps differentiate it from the majority of cases of acute
